STAT Plus: The news from ESMO: An immunotherapy milestone, studying young-onset cancers, and more
ESMO
ESMO news: STAT coverage of the European Society for Medical Oncology 2024 Congress from Barcelona, Spain, plus an archive of coverage from previous meetings of Europe’s leading cancer research society..
Latest
STAT Plus: After 10 years of game-changing immunotherapies, a cancer conference celebrates — and sees more work to do
STAT Plus: Exact Sciences reports initial positive results in colon cancer blood test, but pivot trial still pending
STAT Plus: News from ESMO: An AstraZeneca win in bladder cancer, and more
STAT Plus: AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study
STAT Plus: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial
STAT Plus: Pfizer drug shows promise in cancer-related condition that causes weight loss and weakness
STAT Plus: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study
All Coverage
advertisement
